- 专利标题: Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors
-
申请号: US16591017申请日: 2019-10-02
-
公开(公告)号: US10975088B2公开(公告)日: 2021-04-13
- 发明人: Andrew W. Buesking , Richard B. Sparks , Andrew P. Combs , Brent Douty , Nikoo Falahatpisheh , Lixin Shao , Stacey Shepard , Eddy W. Yue , Artem Shvartsbart , David M. Burns , Daniel Levy
- 申请人: Incyte Corporation
- 申请人地址: US DE Wilmington
- 专利权人: Incyte Corporation
- 当前专利权人: Incyte Corporation
- 当前专利权人地址: US DE Wilmington
- 代理机构: Fish & Richardson P.C.
- 主分类号: A61K31/53
- IPC分类号: A61K31/53 ; C07D487/04 ; C07D471/04 ; C07D519/00
摘要:
This application relates to compounds of Formula (I): or pharmaceutically acceptable salts or stereoisomers thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.
公开/授权文献
- US1263000A Corrugating-machine. 公开/授权日:1918-04-16
信息查询